Bio-Medicine - "Common MS Drugs Taken Together Do Not Reduce Relapse Risk"

New York, NY
 – March 12, 2013  –– 

A recent clinical trial found that interferon╬▓-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together." Our study is the first to investigate if the concurrent use of two drugs with different modes of action would provide any additional clinical benefit without side effects," explains lead author Dr. Fred Lublin, Director of the Corinne Goldsmith Dickinson Center for Multiple Sclerosis at The Mount Sinai Medical Center. Learn more